These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18110885)

  • 1. Quantitative studies on the total plasmin and the trypsin inhibitor of human blood serum; variations in the blood concentration of total plasmin and of trypsin inhibitor in streptococcal diseases with special reference to rheumatic fever.
    TODD EW
    J Exp Med; 1949 Mar; 89(3):309-24. PubMed ID: 18110885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies on the total plasmin and the trypsin inhibitor of human blood serum; methods for the titration of total plasmin and of trypsin inhibitor.
    TODD EW
    J Exp Med; 1949 Mar; 89(3):295-308. PubMed ID: 18110884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum inhibitors of elastase, trypsin, and plasmin in chronic rheumatic diseases.
    Ardelt W; Ksiezny S; Niedzwiecka-Namyslowska I; Budzynski AZ
    Ann Rheum Dis; 1966 Sep; 25(5):450-5. PubMed ID: 4223819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acid-stable inhibitor of trypsin, plasmin and kallikrein from rabbit blood serum].
    Paskhina TS; Nartikova VF
    Vopr Med Khim; 1966; 12(3):325-7. PubMed ID: 4234042
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the inhibition of preparations of porcine plasmin by serum and by urinary trypsin inhibitor (mingin).
    Lauritsen OS
    Scand J Clin Lab Invest; 1965; 17(5):410-2. PubMed ID: 4220984
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):571-91. PubMed ID: 14946321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin.
    Rimon A; Shamash Y; Shapiro B
    J Biol Chem; 1966 Nov; 241(21):5102-7. PubMed ID: 4224456
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.
    Christensen U; Clemmensen I
    Biochem J; 1978 Nov; 175(2):635-41. PubMed ID: 154322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [About degradation products of the inter-alpha-trypsin inhibitor in serum. I. The inter-alpha-trypsin inhibitor as precursor of the acid stable trypsin-plasmin-inhibitor of the serum (author's transl)].
    Hochstrasser K; Niebel J; Feuth H; Lempart K
    Klin Wochenschr; 1977 Apr; 55(7):337-42. PubMed ID: 140269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1 inactivator inhibition by plasmin.
    Harpel PC
    J Clin Invest; 1970 Mar; 49(3):568-75. PubMed ID: 4244455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I. Studies on the determination of fibrinogen in human blood plasma. II. Studies on the trypsin and plasmin inhibitors in human blood serum.
    JACOBSSON K
    Scand J Clin Lab Invest; 1955; 7 Suppl. 14():3-102. PubMed ID: 14372894
    [No Abstract]   [Full Text] [Related]  

  • 12. Trypsin, elastase, plasmin and MMP-9 activity in the serum during the human ageing process.
    Paczek L; Michalska W; Bartlomiejczyk I
    Age Ageing; 2008 May; 37(3):318-23. PubMed ID: 18332058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ON FIBRINOLYSIS IN THE FIELD OF ORTHOPEDIC SURGERY. (2) ON CHANGES IN PLASMIN IN CHRONIC RHEUMATIC FEVER].
    UEDA F; SHIBATA T; NIWA S; WATANABE T; MIKAMI T; HAYASHI H; HANAI K
    Nihon Seikeigeka Gakkai Zasshi; 1964 Oct; 38():692-3. PubMed ID: 14217419
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the stability, inhibition and activation of fibrinolytic protease (tryptase, plasmin).
    FERGUSON JH; LEWIS JH
    Fed Proc; 1948 Mar; 7(1 Pt 1):33. PubMed ID: 18917007
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between plasmin-trypsin-inhibitory and sialyltransferase activities.
    Nadkarni S; Mookerjea S
    Comp Biochem Physiol B Biochem Mol Biol; 1994; 109(2-3):465-71. PubMed ID: 7553356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system.
    Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E
    J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on serum plasmin activity in children. 3. Serum plasmin activity in various pediatric diseases].
    Okamura A
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):323-31. PubMed ID: 4228924
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of trypsin, chymotrypsin, and plasmin by an inhibitor isolated from sheep serum.
    MARTIN CJ
    J Biol Chem; 1962 Jul; 237():2099-104. PubMed ID: 14470337
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some properties of thermolabile trypsin, plasmin and kallikrein inhibitor from rabbit blood serum].
    Paskhina TS; Shimonaeva EE
    Vopr Med Khim; 1967; 13(5):464-71. PubMed ID: 4235108
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
    Pućkowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.